Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment Options
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Solid Tumors|CNS Tumors
Interventions: DRUG: Entrectinib
Sponsor: Hoffmann-La Roche